MOGAMULIZUMAB vs MOGAMULIZUMAB-KPKC: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
MOGAMULIZUMAB vs MOGAMULIZUMAB-KPKC: Safety Overview
| Metric | MOGAMULIZUMAB | MOGAMULIZUMAB-KPKC |
|---|---|---|
| Total FAERS Reports | 441 | 1,186 |
| Deaths Reported | 128 | 161 |
| Death Rate | 29.0% | 13.6% |
| Hospitalizations | 181 | 198 |
| Average Patient Age | 64.5 yrs | 67.9 yrs |
| % Female Patients | 38.1% | 17.6% |
| Manufacturer | Kyowa Kirin, Inc. | N/A |
| Route | INTRAVENOUS | N/A |
| Marketing Status | N/A | Prescription |